| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $199.2M | — | -17.9% |
| Cost of Revenue | $94.8M | — | -6.0% |
| R&D Expense | $19.4M | — | -2.3% |
| SG&A Expense | $67.6M | — | +15.9% |
| Operating Income | -$31.0M | — | -403.4% |
| Pre-tax Income | -$49.4M | — | -341.8% |
| Income Tax | -$1.8M | — | -204.4% |
| Net Income | -$47.6M | — | -354.5% |
| EPS (Basic) | -$1.34 | — | -348.1% |
| EPS (Diluted) | -$1.34 | — | -352.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $162.5M | -8.8% | +44.8% |
| Accounts Receivable | $103.4M | -8.2% | -7.5% |
| Current Assets | $321.2M | -5.1% | +21.7% |
| Total Assets | $1.31B | -3.3% | -1.0% |
| Current Liabilities | $629.1M | +0.1% | +2.3% |
| Long-term Debt | $115.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.4M | — | -31.2% |
| Capital Expenditures | $11.6M | — | +7.3% |
| Investing Cash Flow | -$11.1M | — | +0.8% |
| Financing Cash Flow | -$19.9M | — | -26.1% |
| Free Cash Flow | $5.8M | — | -60.0% |
| -2.5% |
| Total Liabilities | $779.1M | +0.5% | +0.3% |
| Stockholders' Equity | $532.1M | -8.4% | -2.8% |